Abstract Taking 12-N-p-chlorobenzyl sophoridinol 2 as a lead, a series of novel sophoridinic derivatives with various 3 0 -substituents at the 11-side chain were synthesized and evaluated for their anticancer activity from sophoridine (1), a natural antitumor medicine. Among them, the sophoridinic ketones 5a-b, alkenes 7a-b and sophoridinic amines 14a-b displayed reasonable antiproliferative activity with IC 50 values ranging from 3.8 to 5.4 μmol/L. Especially, compounds 5a and 7b exhibited an equipotency in both adriamycin (AMD)-susceptible and resistant MCF-7 breast carcinoma cells, indicating a different mechanism from AMD. The primary mechanism of action of 5a was to arrest the cell cycle at the G0/G1 phase, consistent with that of parent compound 1. Thus, we consider 12-chlorobenzyl sophoridinic derivatives with a tricyclic scaffold to be a new class of promising antitumor agents with an advantage of inhibiting drug-resistant cancer cells.
Introduction
Several quinolizidine alkaloids extracted from Chinese herb Kushen have demonstrated potential antitumor activity [1] [2] [3] [4] . Sophoridine (1, Fig. 1 ), the main active ingredient of Kushen extracts, was approved by the Chinese FDA to treat malignant neoplasm in 2005 5, 6 . Its mechanism is to inhibit the DNA topoisomerase I (topo I) activity and induce cell cycle arrest at the G0/G1 phase [7] [8] [9] . From compound 1, as depicted in Fig. 1 , we have successfully identified that 12-N-substitued sophoridinol derivatives were a promising class of anticancer agents with a novel chemical scaffold and ideal druggable parameters 10, 11 . A representative compound, 12-N-pchlorobenzyl sophoridinol (2, Fig. 1 ) displayed a reasonable antiproliferative activity with an IC 50 of 9.3 μmol/L, much better than that of the parent 1 (480 μmol/L) 10 . Furthermore, it has a couple of advantages such as special scaffold, flexibility structure, high solubility and good safety profiles. In addition, it has an excellent potential for further chemical modifications and optimization 10, 11 . The previous structure-activity relationship (SAR) revealed that 12-N-p-cholobenzyl substituent was beneficial for the antitumor activity 10 . Thus, taking compound 2 as a lead, SAR investigation was continuously developed on the variations of 3 0 -CH 2 OH at the 11-side chain in an effort to discover more potent antitumor candidates. In the present study, as illustrated in Fig. 1 , the 12-N-pcholobenzyl was retained as a required group for activity, and 3 0 -CH 2 OH at 11-attachment was replaced with various substituents and different sophoridinic derivatives were produced. Based on this strategy, a series of sophoridinic ketone, alkene, imine and amine analogs were then constructed and measured. Herein, presented in this study were the synthesis, antitumor assessment, SAR analysis and primary mechanism of action of the representative compounds.
Results and discussion

Synthetic routes
The synthesis of all the newly synthesized compounds was respectively described in Schemes 1 and 2. Each target compound was prepared using commercially available 1 with purity over 98% as the starting material, which was purchased from the Yanchi Dushun Biological and Chemical Co., Ltd. (Shanxi, China). Figure 1 Chemical structures of sophoridine (1) 12-N-p-cholobenzyl sophoridinol (2) and the structural fragments in 2 to be modified.
Scheme 1 Reagents and conditions: (a) HCl, reflux, 6 h; CH 3 OH, r.t., 5-6 h, in 2 steps; (b) R 1 CHO, TEA, 1,2-dichloroethane, reflux, 4 h; STB, reflux, 4 h, in 2 steps; (c) R 2 MgBr (1.0 equiv.), THF, r.t., 7 h; (d) R 2 MgBr (excessive), THF, reflux, 7 h; (e) hydrochloride/ether, r.t., 4 h.
The synthesis of the desired products 12-N-p-cholobenzyl sophoridinic ketones 5a-b and 12-N-p-cholobenzyl sophoridinic alkenes 7a-b was displayed in Scheme 1. The intermediate 3 was obtained through hydrolysis and esterization of 1 in an overall yield of 95% 10, 11 . Then the condensation of 3 with 4-chlorobenzaldehyde followed by the reduction with sodium triacetoxyborohydride (STB) afforded the key intermediate 4 in 53% yield 12 . The nucleophilic-addition reaction of 4 with one molar equivalent of p-Cl-PhMgBr and p-F-PhMgBr in dry THF at room temperature provided products 5a-b with yields of 61%-62% 13 , while the reaction of 4 with excessive amount of Grignard reagents at reflux temperature generated tertiary alcohols 6a-c in 45%-58% yields, which were dehydrated under acidic conditions to give the target alkenes 7a-b with yields of 32%-40%.
As illustrated in Scheme 2, the reduction of 4 in the presence of LiAlH 4 generated sophoridinol 8 in 86% yield, which was converted to sophoridinic aldehyde 9 through a Swern oxidation reaction in 56% yield 14 . The aldol condensation of 9 in HCl/CH 3 OH afforded hemiacetal 10 at room temperature with the yield of 67%, while the condensation of 9 with hydroxylamine hydrochloride afforded hydroxyl oxime 11 in a 72% yield, which went through a methyl etherification to give the oxime ether 12 in 57% yield. The sophoridinic imines 13a-c were obtained via the condensation of 9 and three amines, which were then reduced by sodium cyanoborohydride (NaBH 3 CN) to afford 14a-b in good yields. All desired products were purified by flash chromatography using CH 2 Cl 2 /CH 3 OH as the gradient eluent.
SAR analysis for antitumor activity
All the target compounds were evaluated for their cytotoxic activity in human HepG2 hepatoma cell line using Taxol as a positive control using the MTT assay 15 . Structures of the 11-sophoridinic derivatives and their anti-proliferative activity were shown in Table 1 . The ClogP values were calculated by ChemBioOffice software (Version 12.0).
Taking compound 2 as a lead, the SAR investigation was mainly focused on the variation of 3'-CH 2 OH at the 11-side chain with 12-N-p-cholobenzyl as a required group for antitumor activity. Firstly, in replacing the CH 2 OH group with ketones, the resultant compounds 5a-b with higher lipophilicity (ClogP47.0) displayed improved cytotoxic activity with the IC 50 values of 4.9 μmol/L and 4.0 μmol/L, respectively. Introduction of two methyl groups on the α-carbon adjacent to the hydroxy group led to a tertiary butyric alcohol 6a, which showed a decreased activity with an IC 50 value of 16.3 μmol/L. The replacement of 3 0 -CH 2 OH with an alkene group on the 3'-position created more lipophilic 7a-b, which showed significant improvement on the antiproliferative activity with the IC 50 values of 4.3 and 3.8 μmol/L, respectively, much better than that of 2 and Taxol. The results suggested that a higher ClogP values might be beneficial for good potency against cancer.
Secondly, the generated hemiacetal 10, hydroxyl oxime 11, oxime ether 12 and imines 13a-c abolished cytotoxic activity partially or completely with IC 50 between 11.8 and 450 μmol/L. Considering their potent anticancer effects as well as reasonable ClogP values, compounds 5a and 7b were chosen as the representative compounds for further investigation.
Anti-resistant tumor effect of 5a and 7b
Evaluation of compounds 5a and 7b against drug-resistant cancer cell lines were then carried out. We measured their activity against human wild MCF-7 and adriamycin (AMD)-resistant MCF-7 (MCF-7/AMD) breast carcinoma cells using AMD as a reference control 16 . As depicted in Fig. 2 , AMD was active against wild type MCF-7, and completely inactive in the MCF-7/AMD cells. Meanwhile, compounds 5a and 7b were equipotent or almost equipotent in both MCF-7 cell lines, suggesting a different mode of action from AMD. As compound 5a exhibited an equivalent antiproliferative effect against both MCF-7 cell lines, thus was selected for the next study.
Mechanism of action of 5a
To verify the possible change of mechanism of action after the structure modifications, flow cytometric analysis in the HepG2 cells was conducted. The HepG2 cells were treated for 24 h without or with 5a at concentrations of 1.25, 2.5 and 5.0 μg/mL, respectively. As shown in Fig. 3 , compound 5a arrested the HepG2 cells at the G0/G1 phase as anticipated, indicating a similar mechanism of action to that of its parent compound 1 11 .
Conclusions
A variety of novel sophoridinic derivatives, such as sophoridinic ketones, alkenes, imines and amines, were synthesized and evaluated for their antitumor activity. SAR analysis indicated that the introduction of a suitable methyl amine group on the 3'-position could greatly improve the potency. Compounds 5a and 7b exhibited an equipotent effect in both AMD-susceptible and AMD-resistant breast carcinoma cells, indicating a different mechanism from AMD. The mechanism of action of 5a was to arrest the cell cycle at the G0/ G1 phase, consistent with that of 1. The SAR results provided powerful information for further modifications and optimization of this novel scaffold to identify anticancer candidates that might be active in drug-resistant cancer cells.
Experimental section
Chemistry
Melting point (m.p.) was obtained with a CXM-300 melting point apparatus and uncorrected. The 1 H NMR spectra were performed on a Varian Inova 400 MHz spectrometer (Varian, San Francisco, CA, USA) and 13 C NMR on a Bruker Avance III 400 spectrometer in CD 3 OD or (CD 3 ) 2 SO, using Me 4 Si as a internal standard. ESI high-resolution mass spectra (HR-MS) were recorded on an Autospec UItima-TOF mass spectrometer (Micromass UK Ltd., Manchester, UK). Flash chromatography was performed on a CombiflashRf 200 machine (Teledyne, Nebraska, USA) using silica gel having particle size of 0.038 mm.
General procedures for the synthesis of compound 5
To a solution of 4 (0.50 g, 1.2 mmol) in anhydrous THF (20 mL), 1 mol/L 4-chlorophenylmagnesium bromide or 4-fluorophenylmagnesium bromide (1.2 mL) was slowly added at 0 1C and then stirred at room temperature until TLC analysis showed the completion of the reaction. Then the reaction was quenched by the addition of saturated ammonium chloride solution (5 mL). After the solvent was removed by condensation, dichloromethane (30 mL) was added, and the resultant mixture was washed by water (20 mL) and brine (20 mL), dried over anhydrous sodium sulfate, concentrated, and the residue was purified by flash column chromatography on silica gel with CH 2 Cl 2 /CH 3 OH as the eluents to afford target compounds. (6) . To a solution of 4 (0.50 g, 1.2 mmol, 1.0 equiv.) in anhydrous THF (20 mL), solution of methylmagnesium bromide (4.0 equiv.) in THF was slowly added at 0 1C and then stirred at room temperature until TLC analysis showed completion of the reaction. Then the reaction was quenched by the addition of saturated ammonium chloride solution (5 mL). After the solvent was removed by condensation, dichloromethane (30 mL) was added, and the resultant mixture was washed by water (20 mL) and brine (20 mL), dried over anhydrous sodium sulfate, concentrated, and the residue was purified by flash column chromatography on silica gel with CH 2 
12-N-p-Chlorobenzyl sophoridinic hemiacetal (10)
A dry, 250-mL, three-necked, round-bottomed flask equipped with a magnetic stirrer and a dropping funnel was charged with 100 mL of dry dichloromethane under an atmosphere of nitrogen. After cooling to À78 1C, oxalyl chloride (1.0 mL, 12 mmol ) and dry dimethyl sulfoxide (1.5 mL, 20 mmol) were added dropwise to the stirred solution. After 5 min, 8 (3.7 g, 10 mmol) in 20 mL of dichloromethane was added with stirring. The mixture was stirred for an additional 0.5 h at À 78 1C, and freshly distilled triethylamine (5.6 mL, 40 mmol) was added. The mixture was then allowed to warm to room temperature over 0.5 h, whereupon 50 mL of water is added. The phases are separated, and the aqueous phase is extracted three times with 50 mL of diethyl ether or dichloromethane. The combined organic phases were washed successively with water (50 mL) and brine (50 mL). The organic layer was dried over anhydrous magnesium sulfate, and the solvent was removed under reduced pressure, and the residue was purified by flash column chromatography on silica gel with CH 2 Cl 2 /CH 3 OH as the eluents to afford compound 9 as a yellow viscous solid, to which 1 mol/L hydrochloric acid-methanol solution (10 mL) was added and stirred at room temperature for 10 min, removal of the solvent generated target compound 10 as a white solid. Yield: 67%, m. 28 (m, 1H), 2.25-1.97 (m, 4H), 1.94-1.69 (m, 4H), 1.72-1.48  (m, 6H), 1.47-0.94 (m, 6H) ; 13 C NMR (126 MHz, CD 3 OD) δ 140.2, 133.4, 131.0 (2), 129.2 (2), 99.6, 65.0, 64.9, 60.2, 58.9,  55.1, 52.6, 46.2, 39.1, 30.2, 28.4, 26.4, 26.0, 23.8, 23.7 
12-N-p-lorobenzyl sophoridinic hydroxyl oxime bihydrochloride (11)
To a mixture of hydroxylamine hydrochloride (0.25 g, 3.6 mmol) in 20% sodium hydroxide solution (70 mL), 9 (1.1 g, 3.0 mmol) was added and the mixture was stirred at room temperature until TLC analysis showed the completion of the reaction. The insoluble solid was filtered off and the solvent was removed by condensation, and the residue was purified by flash column chromatography on silica gel with CH 2 Cl 2 /CH 3 OH as the eluents to obtain the free form of 11 as colorless oil, which was then acidified by 3 mol/L HCl/ether (10 mL) to afford 11 as a white solid. Yield: 72%, m.p.: 91-92 1C; 4.1.6. 12-N-p-Chlorobenzyl-4 0 -N-morpholin-sophoridinic imine (13) To a mixture of 9 (1.1 g, 3.0 mmol) in anhydrous methanol (50 mL), 4-amine-morpholin (0.43 mL, 4.5 mmol) was added and the mixture was refluxed for 4 h before cooled to room temperature. The solvent was condensed and dichloromethane (50 mL) was added, and the mixture was washed successively with water (30 mL) and saturated ammonium chloride solution (30 mL). The mixture was evaporated and the residue was purified by flash column chromatography on silica gel with CH 2 Cl 2 /CH 3 OH as the eluents to obtain the target compound 13 as a white solid. 0 -(4-chloro-3-trifluoromethylphenyl)sophoridinic amine trihydrochloride (14a). To a mixture of 9 (1.1 g, 3.0 mmol) in anhydrous methanol (50 mL), 4-chloro-3-trifluoromethylphenylamine (0.8 g, 4.5 mmol) was added and the mixture was refluxed for 4 h, then sodium cyanoborohydride (0.9 g, 4.5 mmol) was added portion wise, and the mixture was refluxed for another 4 h. The mixture was cooled to room temperature and evaporated, then dichloromethane (50 mL) was added, and the mixture was washed successively with water (30 mL) and saturated ammonium chloride solution (30 mL). The mixture was evaporated and the residue was purified by flash column chromatography on silica gel with CH 2 Cl 2 /CH 3 OH as the eluents, then acidified by 3 mol/L HCl/ether (10 mL) and filtrated to obtain the target compound 14a as a white solid. 
Cell cycle distribution assay
HepG2 cells were treated with 5a at different concentrations for 24 h and then cells were harvested. Cells were fixed with 70% ethanol and stored at -20 1C overnight. The fixed cells were incubated with 200 μg/mL RNase at 37 1C for 30 min and then stained with 50 μg/mL propidium iodide in the dark for 30 min. Cell cycle distribution was then analyzed by flow cytometry using FACS analysis (BD FACSCalibur, USA).
